Target intelligence / Profile preview

Cardiac afterload (null)

Target
null
Molecular classification
Other (hemodynamic parameter; not a molecule, receptor, or gene)
01

Overview

Cardiac afterload is a term describing the pressure or resistance that the heart, particularly the left ventricle, must overcome to eject blood into the aorta during systole. It is primarily determined by systemic vascular resistance and aortic pressure for the left heart, and pulmonary artery pressure for the right heart. Quantitatively, afterload can be estimated using formulas derived from the Law of Laplace, involving ventricular wall stress, chamber radius, and wall thickness. Physiologically, increased afterload reduces stroke volume and cardiac output, and persistent elevation contributes to pathological cardiac hypertrophy and heart failure. Afterload is not a molecular or pharmacological target itself, but it is influenced by various drugs used in the management of cardiovascular diseases, mainly by reducing vascular resistance.

Other names
AfterloadVentricular afterloadVascular afterload
02

Mechanism of action

Drugs affecting afterload generally act by decreasing systemic vascular resistance or reducing aortic/pulmonary pressure, thereby lowering the "load" the heart must overcome to eject blood

03

Biological functions

Regulates ventricular ejectionImpacts stroke volumeInfluences cardiac output
04

Disease associations

Cardiovascular disease (as an influencing factor, e.g., in hypertension, heart failure)Heart failure (increase in afterload contributes to pathological cardiac hypertrophy)
05

Safety considerations

Excessive reduction in afterload (e.g., from aggressive vasodilation) can result in hypotension and inadequate perfusionExcessively increased afterload can exacerbate heart failure, cause ventricular hypertrophy, and increase myocardial oxygen demand
06

Interacting drugs

Hydralazine

4 more in the full profile.

07

Biomarkers

Systolic blood pressureSystemic vascular resistanceAortic pressure

Beyond the preview

Go deeper on Cardiac afterload (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiac afterload (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call